UniProt ID | PP4C_HUMAN | |
---|---|---|
UniProt AC | P60510 | |
Protein Name | Serine/threonine-protein phosphatase 4 catalytic subunit | |
Gene Name | PPP4C | |
Organism | Homo sapiens (Human). | |
Sequence Length | 307 | |
Subcellular Localization | Cytoplasm. Nucleus. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome. | |
Protein Description | Protein phosphatase that is involved in many processes such as microtubule organization at centrosomes, maturation of spliceosomal snRNPs, apoptosis, DNA repair, tumor necrosis factor (TNF)-alpha signaling, activation of c-Jun N-terminal kinase MAPK8, regulation of histone acetylation, DNA damage checkpoint signaling, NF-kappa-B activation and cell migration. The PPP4C-PPP4R1 PP4 complex may play a role in dephosphorylation and regulation of HDAC3. The PPP4C-PPP4R2-PPP4R3A PP4 complex specifically dephosphorylates H2AFX phosphorylated on Ser-140 (gamma-H2AFX) generated during DNA replication and required for DNA double strand break repair. Dephosphorylates NDEL1 at CDK1 phosphorylation sites and negatively regulates CDK1 activity in interphase (By similarity). In response to DNA damage, catalyzes RPA2 dephosphorylation, an essential step for DNA repair since it allows the efficient RPA2-mediated recruitment of RAD51 to chromatin.. | |
Protein Sequence | MAEISDLDRQIEQLRRCELIKESEVKALCAKAREILVEESNVQRVDSPVTVCGDIHGQFYDLKELFRVGGDVPETNYLFMGDFVDRGFYSVETFLLLLALKVRYPDRITLIRGNHESRQITQVYGFYDECLRKYGSVTVWRYCTEIFDYLSLSAIIDGKIFCVHGGLSPSIQTLDQIRTIDRKQEVPHDGPMCDLLWSDPEDTTGWGVSPRGAGYLFGSDVVAQFNAANDIDMICRAHQLVMEGYKWHFNETVLTVWSAPNYCYRCGNVAAILELDEHLQKDFIIFEAAPQETRGIPSKKPVADYFL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MAEISDLDR ------CCCHHHHHH | 23.88 | 22223895 | |
15 | Methylation | DRQIEQLRRCELIKE HHHHHHHHHCHHHCH | 40.68 | 115488613 | |
21 | Acetylation | LRRCELIKESEVKAL HHHCHHHCHHHHHHH | 68.74 | 26051181 | |
21 | Ubiquitination | LRRCELIKESEVKAL HHHCHHHCHHHHHHH | 68.74 | - | |
26 | Ubiquitination | LIKESEVKALCAKAR HHCHHHHHHHHHHHH | 31.43 | 21906983 | |
31 | Ubiquitination | EVKALCAKAREILVE HHHHHHHHHHHHHHC | 47.16 | 21906983 | |
31 | Acetylation | EVKALCAKAREILVE HHHHHHHHHHHHHHC | 47.16 | 25953088 | |
47 | Phosphorylation | SNVQRVDSPVTVCGD CCCCCCCCCEEEECC | 20.57 | 27732954 | |
50 | Phosphorylation | QRVDSPVTVCGDIHG CCCCCCEEEECCCCC | 17.29 | 27251275 | |
63 | Ubiquitination | HGQFYDLKELFRVGG CCCEECHHHHHCCCC | 49.85 | 21906983 | |
77 | Phosphorylation | GDVPETNYLFMGDFV CCCCCCCEEECCCCC | 14.56 | - | |
104 | Phosphorylation | LLALKVRYPDRITLI HHHHHCCCCCCEEEE | 16.69 | 28509920 | |
107 | Methylation | LKVRYPDRITLIRGN HHCCCCCCEEEEECC | 21.20 | 115488619 | |
109 | Phosphorylation | VRYPDRITLIRGNHE CCCCCCEEEEECCCC | 19.61 | 28509920 | |
121 | Phosphorylation | NHESRQITQVYGFYD CCCHHHHHEEEECHH | 12.02 | 24043423 | |
124 | Phosphorylation | SRQITQVYGFYDECL HHHHHEEEECHHHHH | 7.53 | 28152594 | |
127 | Phosphorylation | ITQVYGFYDECLRKY HHEEEECHHHHHHHH | 13.38 | 28152594 | |
133 | Ubiquitination | FYDECLRKYGSVTVW CHHHHHHHHCCEEHH | 40.80 | - | |
168 | Phosphorylation | FCVHGGLSPSIQTLD EEEECCCCCCHHCHH | 21.63 | 25693802 | |
170 | Phosphorylation | VHGGLSPSIQTLDQI EECCCCCCHHCHHHH | 24.77 | 25693802 | |
173 | Phosphorylation | GLSPSIQTLDQIRTI CCCCCHHCHHHHCCC | 30.54 | 25693802 | |
183 | Ubiquitination | QIRTIDRKQEVPHDG HHCCCCCCCCCCCCC | 47.24 | - | |
193 | Glutathionylation | VPHDGPMCDLLWSDP CCCCCCCCCEEECCC | 3.62 | 22555962 | |
242 | Sulfoxidation | CRAHQLVMEGYKWHF HHHHHHHHCCCCEEE | 4.49 | 30846556 | |
298 | Phosphorylation | QETRGIPSKKPVADY CCCCCCCCCCCCHHH | 51.93 | 24719451 | |
299 | Ubiquitination | ETRGIPSKKPVADYF CCCCCCCCCCCHHHC | 56.60 | - | |
300 | Acetylation | TRGIPSKKPVADYFL CCCCCCCCCCHHHCC | 49.41 | 25953088 | |
300 | Ubiquitination | TRGIPSKKPVADYFL CCCCCCCCCCHHHCC | 49.41 | - | |
305 | Phosphorylation | SKKPVADYFL----- CCCCCHHHCC----- | 9.31 | 27642862 | |
307 | Methylation | KPVADYFL------- CCCHHHCC------- | 5.81 | 25130464 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of PP4C_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
307 | L | Methylation |
| 25130464 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PP4C_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. |